Efficacy News and Research

RSS
Building a comprehensive child vision care system

Building a comprehensive child vision care system

Study looks at imipramine in the treatment of irritable bowel syndrome

Study looks at imipramine in the treatment of irritable bowel syndrome

Tiotropium - corticosteroid combination improves lung disease survival

Tiotropium - corticosteroid combination improves lung disease survival

Cannabis Science reports on future plans for cannabis drug trials

Cannabis Science reports on future plans for cannabis drug trials

Neurologix announces Q2 2009 financials

Neurologix announces Q2 2009 financials

Health Canada approves Multaq (Dronedarone) for atrial fibrillation

Health Canada approves Multaq (Dronedarone) for atrial fibrillation

Forest Labs and Astrazeneca to co-develop and commercialize ceftaroline

Forest Labs and Astrazeneca to co-develop and commercialize ceftaroline

Investigational, orally-inhaled therapy effective in treating migraines

Investigational, orally-inhaled therapy effective in treating migraines

Endocyte announces results from study of EC145 in patients with advanced non-small cell lung cancer

Endocyte announces results from study of EC145 in patients with advanced non-small cell lung cancer

Neoprobe announces Q2 financials

Neoprobe announces Q2 financials

Labopharm submits response to FDA for formulation of the antidepressant trazodone

Labopharm submits response to FDA for formulation of the antidepressant trazodone

Vertebroplasty expert cites concerns about new study

Vertebroplasty expert cites concerns about new study

Experimental treatment for multiple sclerosis reverses disorder in mice

Experimental treatment for multiple sclerosis reverses disorder in mice

Upstream Biosciences actively seeking licensors or acquirers for anti-parasitic drug discovery portfolio and cancer diagnostic platform

Upstream Biosciences actively seeking licensors or acquirers for anti-parasitic drug discovery portfolio and cancer diagnostic platform

Holography helps tackle ovarian cancer

Holography helps tackle ovarian cancer

Depomed reports promising results in phase I trial for DM-1992 in Parkinson’s

Depomed reports promising results in phase I trial for DM-1992 in Parkinson’s

Additional trial to be conducted for KYNAPID under FDA special protocol agreement

Additional trial to be conducted for KYNAPID under FDA special protocol agreement

Eiger Biopharmaceuticals starts CLEAN-1 HCV phase 1B trial

Eiger Biopharmaceuticals starts CLEAN-1 HCV phase 1B trial

Electrodiagnostic and neuromuscular medicine featured at AANEM annual meeting

Electrodiagnostic and neuromuscular medicine featured at AANEM annual meeting

Array Biopharma reports Q4 and full year 2009 financials

Array Biopharma reports Q4 and full year 2009 financials

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.